Skip to main content
SpringerLink
Log in

Safety and Effectiveness of Nitroprusside in Preventing No-Reflow During Percutaneous Coronary Intervention: A Systematic Review

  • Translational Biomedical Research
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

The objective of this study was to evaluate the clinical efficacy and safety of nitroprusside injection for preventing the slow-flow/no-reflow phenomenon after percutaneous coronary intervention (PCI). We searched the Cochrane Central Register of Controlled Trials (Issue 2, 2011), PubMed, EMbase, and Google Scholar for data. Two reviewers independently evaluated the quality of the included studies and extracted the data. A meta-analysis was performed using RevMan 5.0 software. Four randomized controlled trials (RCTs) involving 319 patients were included. The results of the meta-analyses showed that intracoronary nitroprusside is beneficial in preventing no-reflow/slow-flow, in reducing corrected TIMI frame count, and in improving left ventricular ejection fraction. It also likely reduces adverse reactions in patients after PCI and rehospitalization due to cardiovascular events. However, we must caution that in this review, there is a moderate possibility of bias with regard to patient selection, performance, and publication because of the small number of included studies. A larger sample size and high-quality RCTs are needed for a more reassuring analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Keeley, E. C., Boura, J. A., & Grines, C. L. (2003). Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet, 361, 13–20.

    Article  PubMed  Google Scholar 

  2. Kloner, R. A., Ganote, C. E., & Jennings, R. B. (1974). The no-reflow phenomenon after temporary coronary occlusion in the dog. Journal of Clinical Investigation, 54, 1496–1508.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Kelly, R. V., Cohen, M. G., & Stouffer, G. A. (2005). Incidence and management of “no-reflow” following percutaneous coronary interventions. American Journal of the Medical Sciences, 329, 78–85.

    Article  CAS  PubMed  Google Scholar 

  4. Akdemir, R., Karakurt, O., Kilic, H., et al. (2010). Effect of reperfusion therapy on index of myocardial performance in acute myocardial infarction: Thrombolytics versus primary angioplasty. Heart and Vessels, 25, 87–91.

    Article  PubMed  Google Scholar 

  5. Bates, J. N., Baker, M. T., Guerra, R, Jr, & Harrison, D. G. (1991). Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochemical Pharmacology, 42(Suppl), S157–S165.

    Article  CAS  PubMed  Google Scholar 

  6. Pan, W., Wang, L. F., Yu, J. H., et al. (2009). Intracoronary nitroprusside in the prevention of the no-reflow phenomenon in acute myocardial infarction. Chinese Medical Journal, 122, 2718–2723.

    PubMed  Google Scholar 

  7. Hendler, A., Aronovich, A., Kaluski, E., et al. (2006). Optimization of myocardial perfusion after primary coronary angioplasty following an acute myocardial infarction. Beyond TIMI 3 flow. Journal of Invasive Cardiology, 18, 32–36.

    PubMed  Google Scholar 

  8. Amit, G., Cafri, C., Yaroslavtsev, S., et al. (2006). Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial. American Heart Journal, 152, 887.e9–887.e14.

    Article  Google Scholar 

  9. Sakamoto, H., Shimamoto, S., Kawase, Y., Ueda, H., Murakami, T., & Tamura, T. (2010). Effect of nitroprusside on reducing infarct size after primary percutaneous coronary intervention for acute myocardial infarction. Journal of the American College of Cardiology, 55, A104.E968.

    Google Scholar 

  10. Valero, S. J., Moreno, R., Reyes, R. M., et al. (2008). Pharmacological approach of no-reflow phenomenon related with percutaneous coronary interventions. Cardiovascular and Hematological Agents in Medicinal Chemistry, 6, 125–129.

    Article  CAS  PubMed  Google Scholar 

  11. Gibson, C. M., & Schomig, A. (2004). Coronary and myocardial angiography: Angiographic assessment of both epicardial and myocardial perfusion. Circulation, 109, 3096–3105.

    Article  PubMed  Google Scholar 

  12. Tesic, M. B., Stankovic, G., Vukcevic, V., & Ostojic, M. C. (2010). The use of intracoronary sodium nitroprusside to treat no-reflow after primary percutaneous coronary intervention in acute myocardial infarction. Herz, 35, 114–118.

    Article  PubMed  Google Scholar 

  13. Airoldi, F., Briguori, C., Cianflone, D., et al. (2007). Frequency of slow coronary flow following successful stent implantation and effect of nitroprusside. American Journal of Cardiology, 99, 916–920.

    Article  CAS  PubMed  Google Scholar 

  14. Pasceri, V., Pristipino, C., Pelliccia, F., et al. (2005). Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction. American Journal of Cardiology, 95, 1358–1361.

    Article  CAS  PubMed  Google Scholar 

  15. Kiernan, T. J., Ruggiero, N. J, I. I., Bernal, J. M., et al. (2009). The no-reflow phenomenon in the coronary circulation. Cardiovascular and Hematological Agents in Medicinal Chemistry, 7, 181–192.

    Article  CAS  PubMed  Google Scholar 

  16. Kitakaze, M., Asakura, M., Kim, J., et al. (2007). Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): Two randomised trials. Lancet, 370, 1483–1493.

    Article  CAS  PubMed  Google Scholar 

  17. Marzilli, M., Orsini, E., Marraccini, P., & Testa, R. (2000). Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation, 101, 2154–2159.

    Article  CAS  PubMed  Google Scholar 

  18. Ross, A. M., Gibbons, R. J., Stone, G. W., Kloner, R. A., & Alexander, R. W. (2005). A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). Journal of the American College of Cardiology, 45, 1775–1780.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China

    Qiang Su, Lang Li, Kyaw Aung Naing & Yuhan Sun

Authors
  1. Qiang Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kyaw Aung Naing
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuhan Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lang Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Su, Q., Li, L., Naing, K.A. et al. Safety and Effectiveness of Nitroprusside in Preventing No-Reflow During Percutaneous Coronary Intervention: A Systematic Review. Cell Biochem Biophys 68, 201–206 (2014). https://doi.org/10.1007/s12013-013-9690-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-013-9690-9

Keywords

Search

Navigation